Terminalia buceras
Terminalia buceras · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Terminalia buceras is a botanical species that has gained significant scientific interest due to its diverse pharmacological potential. Research into its leaf extracts, particularly in aqueous forms, has revealed potent biological activities including antitumor, antifungal, and cytotoxic properties. The plant contains specialized chemical compounds such as 3-hydroxyminimiflorin, 3-methoxyminimiflorin, Buceracidin A, and Buceracidin B. These bioactive constituents have demonstrated specific efficacy in addressing conditions involving pathogens like Aspergillus niger. Consequently, studying these leaf preparations offers promising avenues for developing new therapeutic agents.
- Synonyms
- Myrobalanus Buceras · Bucida Buceras · 4 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Common Names
Terminalia buceras is a versatile species known by a diverse array of regional names. It is frequently referred to as the Antigua Whitewood, highlighting its distinct timber qualities. In other parts of the world, it is commonly identified as the Black Olive or the Bullet tree. Local dialects further enrich its identity, with names such as Cacho de toro being used to describe it. Finally, the plant is also recognized by the name Ciriam, reflecting the many ways it is categorized across different cultures.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia buceras is a species that has historically been identified through a wide variety of botanical names. Within scientific literature, you may encounter it listed under several different synonyms, such as Buceras bucida or Bucida buceras. The plant's complex taxonomic history also includes classifications like Bucida ophiticola and Bucida palustris. Furthermore, researchers have previously referred to this specimen as Bucida subinermis in various studies. Understanding these overlapping names is essential for anyone studying the diverse nomenclature associated with this tree.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia buceras is a distinctive botanical specimen belonging to the vast kingdom Plantae. Within this biological realm, the species is classified under the class Equisetopsida. It further resides in the order Myrtales, showcasing its specific evolutionary lineage. As a member of the genus Terminalia, it shares characteristics with several related woody plants. Ultimately, this tree is a prominent representative of the family Combretaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia buceras maintains a widespread presence across various regions of North America, particularly within the diverse landscapes of Mexico. Its distribution extends through the central, gulf, southeast, and southwest territories of the Mexican landscape. In addition to its Mexican range, the species can be found thriving within the Southeastern United States. Florida serves as a key location for this plant's natural habitat within the American South. This broad geographic reach highlights the plant's adaptability to different subtropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia buceras is a self-supporting tree characterized by its sturdy growth form. This species typically reaches a maximum height of 15 meters as it matures. Its structural stability makes it a prominent feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia buceras, also known as Bucida buceras, has demonstrated significant medicinal potential through its diverse biological activities. Research indicates that the plant contains specific compounds, such as bucidarasins A-C, which exhibit potent cytotoxic properties against human tumor cell lines. These findings suggest that the species possesses strong antitumor activity, even maintaining effectiveness against drug-resistant lines. Beyond its cancer-fighting potential, the plant has also proven to be a highly effective antifungal agent. Specifically, leaf extracts from the species showed superior ability to inhibit several phytopathogenic fungi, marking it as a valuable candidate for developing natural biopesticides.
Compounds
Terminalia buceras, also known as Bucida buceras, serves as a rich source of diverse prenylated flavanones. Research into this rainforest plant has identified several key compounds, including the newly discovered buceracidin A and buceracidin B. In addition to these new isolates, the plant contains the known flavanones minimiflorin, 3-hydroxyminimiflorin, and 3-methoxyminimiflorin. These specific chemical constituents are of particular interest due to their potential roles as antitumor agents. Studies suggest that several of these compounds exhibit marginal cytotoxicity against human tumor cell lines.
Conditions
Terminalia buceras, also identified in the research as Bucida buceras, exhibits significant antifungal properties against several phytopathogenic fungi. Specifically, the plant's extracts are effective in treating Aspergillus niger and Aspergillus parasiticus. It also demonstrates the ability to treat Colletotricum gloeosporioides and Fusarium oxysporum. Furthermore, the plant extracts provide medicinal benefits by inhibiting the production of LasA protease in Pseudomonas aeruginosa. These diverse biological activities highlight the plant's potential for both antifungal and quorum-quenching applications.
Preparations
Terminalia buceras, also referred to as Bucida buceras in the provided abstracts, is prepared as aqueous extracts to evaluate its potential in inhibiting the virulence of Pseudomonas aeruginosa. These aqueous extracts have been shown to prevent nematode mortality and reduce death caused by toxin production in infection-based assays. Additionally, the plant is prepared as leaf extracts to investigate its medicinal properties against various phytopathogenic fungi. Specifically, these leaf extracts demonstrated significant antifungal activity, showing high efficacy against pathogens such as P. expansum and F. oxysporum. Through these different preparation methods, the plant's potential as both an anti-infective and a biopesticide is highlighted.
Parts used
Terminalia buceras serves as a significant subject of study regarding the medicinal potential of plant extracts. Researchers specifically utilized the leaf of this species to investigate its inherent antimicrobial properties. The study focused on how these leaf extracts could act as a non-toxic, cost-effective alternative to chemical fungicides. Notably, the plant demonstrated exceptional efficacy by exhibiting the best antifungal activity against several phytopathogenic fungi. These findings highlight the importance of utilizing specific plant parts to develop effective biopesticides for the agricultural industry.